Skip to content

The effect of neurofeedback therapy in reducing relapse and craving for methamphetamine dependent patients

The effect of neurofeedback therapy in reducing relapse and craving for methamphetamine dependent patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017021828967N5
Enrollment
100
Registered
2017-03-01
Start date
2017-04-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction. Mental and behavioral disorders due to use of other stimulants, including caffeine: dependence syndromes

Interventions

Intervention 1: The experimental group will receive neurofeedback treatment in 30 sessions. Intervention 2: The control group will receive unrealistic neurofeedback therapy in 30 sessions.
Treatment - Other
The experimental group will receive neurofeedback treatment in 30 sessions.
The control group will receive unrealistic neurofeedback therapy in 30 sessions.

Sponsors

Vice chancellor for research, Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Inclusion criteria: Gender Male; Methamphetamine dependence diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders fifth edition; The dominant use of methamphetamine for at least 6 months, lack of serious psychiatric disorders. Exclusion criteria: Gender female; No use of other drugs and stimulants at the time of entering the study; The absence of comorbid psychiatric disorders symptoms.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Relapse. Timepoint: before intervention- 4 weeks later- 8 weeks later. Method of measurement: Relapse Questionnaire.;Craving. Timepoint: before intervention- 4 weeks later- 8 weeks later. Method of measurement: Craving Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Vahid Farnia

Kermanshah University of Medical Sciences

vfarnia@yahoo.com+98 83 3826 4513

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026